HF
COCP icon

HRT Financial’s Cocrystal Pharma COCP Stock Holding History

HRT Financial’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
+20,336
New +$25K ﹤0.01% 3916
2022
Q3 		– Sell
-1,042
Closed -$5K – 2890
2022
Q2 		$5K Buy
+1,042
New +$5.55K ﹤0.01% 2739

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial's COCP Position: Q2 2026 in Review

HRT Financial opened a new position in Cocrystal Pharma (COCP) in Q2 2026: 20,336 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #3916 among its holdings. This is a return to the name: HRT Financial previously reported a position in COCP as recently as Q2 2022.

HRT Financial first reported a position in COCP in Q2 2022 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • HRT Financial held 20,336 shares of Cocrystal Pharma worth $21K as of Q2 2026.
  • Cocrystal Pharma was a new HRT Financial position in Q2 2026.
  • Cocrystal Pharma made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3916 holding.
  • HRT Financial first reported a position in Cocrystal Pharma in Q2 2022 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.